Pfizer Inc.’s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug ...

The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its ...

Key Takeaways Pfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...

Starboard Value, an activist investment firm, has taken a significant $1 billion stake in Pfizer, signaling its intent to ...

The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic ...

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories.